Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30290902

Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2018 Oct
First author
Locatelli F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2018 Oct;5(10):e433-e434. doi: 10.1016/S2352-3026(18)30160-1.
    note
    Source null
    related pmid
    30290898
    relationship
    Comment in

Authors and identifiers

  1. name
    Locatelli F
    type
    Author
  2. name
    Mauz-Koerholz C
    type
    Author
  3. name
    Neville K
    type
    Author
  4. name
    Llort A
    type
    Author
  5. name
    Beishuizen A
    type
    Author
  6. name
    Daw S
    type
    Author
  7. name
    Pillon M
    type
    Author
  8. name
    Aladjidi N
    type
    Author
  9. name
    Klingebiel T
    type
    Author
  10. name
    Landman-Parker J
    type
    Author
  11. name
    Medina-Sanson A
    type
    Author
  12. name
    August K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Locatelli F
    type
    Author
  2. name
    Mauz-Koerholz C
    type
    Author
  3. name
    Neville K
    type
    Author
  4. name
    Llort A
    type
    Author
  5. name
    Beishuizen A
    type
    Author
  6. name
    Daw S
    type
    Author
  7. name
    Pillon M
    type
    Author
  8. name
    Aladjidi N
    type
    Author
  9. name
    Klingebiel T
    type
    Author
  10. name
    Landman-Parker J
    type
    Author
  11. name
    Medina-Sanson A
    type
    Author
  12. name
    August K
    type
    Author
bibliography ids
  1. nci-bib-aa13eaabc539ecb60b4512c8
book metadata
content sha256
8c5c1f478a9226cf41d4eed786f8f260e4853877022b2c84c8d15cfd29a6e341
document type
citation
dois
  1. 10.1016/S2352-3026(18)30153-4
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:30290902
immutable id
pubmed:30290902@8c5c1f478a9226cf41d4eed786f8f260e4853877022b2c84c8d15cfd29a6e341
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
10
name
The Lancet. Haematology
nlm unique id
101643584
pages
e450-e461
volume
5
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2018 Oct;5(10):e433-e434. doi: 10.1016/S2352-3026(18)30160-1.
    note
    Source null
    related pmid
    30290898
    relationship
    Comment in
outcomes validated
false
pmid
30290902
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
8dcf6ba36346305c5cd1460d507c1f6f866c3cde6c18357d62ab8bdb1e11fdaf
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Oct
precision
month
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30290902/
title
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.

Preserved source evidence · Not medical advice